Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000889910 | SCV001033626 | likely benign | not provided | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495386 | SCV002799179 | likely benign | Hermansky-Pudlak syndrome 1 | 2021-10-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001836000 | SCV002086565 | benign | Hermansky-Pudlak syndrome | 2019-10-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003940654 | SCV004754239 | likely benign | HPS1-related disorder | 2019-12-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |